Ten years ago, when gene therapy first entered the clinical scene, Bob Cuddihy felt it wasn’t quite ready for prime time. Robert Cuddihy “But with all of the discoveries in technology, all the improvements we’ve been seeing over that preceding decade, I really think all the tools are there now to really watch this field…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
